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MinireviewEpithelial-Mesenchymal Transitions:
Twist in Development and Metastasis
that EMT is an important, if transient, event in the pro-
gression of many carcinomas, and it may be a perma-
nent feature in tumors that have a mixed carcinoma/
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A hallmark of EMT is the loss of E-cadherin expres-1275 York Avenue
sion. E-cadherin is a central component of cell-cell ad-New York, New York 10021
hesion junctions and is required for the formation of
epithelia in the embryo and to maintain epithelial homeo-
stasis in the adult. Loss of E-cadherin is consistentlyEpithelial-mesenchymal transitions (EMT) are vital for
observed at sites of EMT during development and can-morphogenesis during embryonic development and
cer. This loss increases tumor cell invasiveness in vitroare also implicated in the conversion of early stage
and contributes to the transition of adenoma to carci-tumors into invasive malignancies. Several key in-
noma in animal models (Thiery, 2002). The expressionducers of EMT are transcription factors that repress
level of E-cadherin often is inversely correlated withE-cadherin expression. A recent report in Cell (Yang
tumor grade and stage. Furthermore, inactivating muta-et al., 2004) adds Twist to this list and links EMT to
tions in E-cadherin have been found in about 50% ofthe ability of breast cancer cells to enter the circulation
breast lobular carcinomas. Individuals who inherit oneand seed metastases.
mutant allele of E-cadherin are at high risk of developing
diffuse gastric carcinoma. By these criteria at least,Tumors are often viewed as corrupt forms of normal
E-cadherin is a tumor suppressor gene. Although muta-developmental processes. Indeed, genes that are im-
tional inactivation of the second allele has not beenportant in embryonic development are frequently found
observed, E-cadherin expression is frequently inhibitedto be culprits in cancer. Conversely, genes discovered
by various epigenetic mechanisms (Thiery, 2002). Pro-for their oncogenic role are often found to be key players
moter hypermethylation accounts for the loss of E-cad-in embryogenesis. This trend applies to the steps that
herin expression in some tumors cells. In many otherinitiate tumor formation. It also applies to the steps that
cases, E-cadherin expression is inhibited by transcrip-mediate tumor progression, including local invasion,
tional repression.spread through the circulation and, most devastatingly,
Several developmentally important genes that inducemetastasis. In this context, EMT, a process first appreci-
EMT have been shown to act as E-cadherin repressors.ated by developmental biologists, is attracting increas-
The first of these is the zinc finger protein Snail, a DNAing attention from oncologists. Genes implicated in EMT
binding factor that recognizes E box motifs in targetduring embryogenesis are turning up, one after the
promoters, including the E-cadherin promoter (reviewedother, in tumorigenesis. The recent addition of Twist to
in Nieto [2002]). In Drosophila, Snail is specifically ex-this list (Yang et al., 2004) provides not only a new player
pressed in invaginating mesodermal cells just beforebut also some of the best evidence to date for a specific
they undergo EMT. Snail null flies have severe defectsrole of EMT in the movement of cells from a primary
in mesoderm formation. In vertebrates, Snail and thetumor into the circulation.
closely related gene Slug are essential for gastrulationEMT is a process whereby epithelial cell layers lose
and neural crest emergence from the neural tube. Snail
polarity and cell-cell contacts and undergo a dramatic
has been shown to be a transcriptional repressor of
remodeling of the cytoskeleton (Thiery, 2002). Concur-
E-cadherin and a mediator of EMT in mouse and human
rent with a loss of epithelial cell adhesion and cytoskele- invasive carcinoma cells (Nieto, 2002). Another repres-
tal components, cells undergoing EMT acquire expres- sor of E-cadherin and inducer of EMT is the zinc finger
sion of mesenchymal components and manifest a protein SIP1 (ZEB-2) (Comijn et al., 2001). SIP1 and Snail
migratory phenotype. This type of conversion occurs bind to partly overlapping E boxes in the E-cadherin
during many critical steps of metazoan embryogenesis. promoter, with similar repressor effects. SIP1 is highly
The morphogenic movements underlying gastrulation expressed in several E-cadherin-deficient human carci-
and the subsequent formation of various tissues and noma cell lines. When overexpressed, Snail and SIP1
organs such as the neural crest, heart, musculoskeletal abrogate E-cadherin-mediated intercellular adhesion
system, craniofacial structures, and peripheral nervous and promote tumor cell invasion. The findings of Yang
system all rely on EMT. EMT is also implicated in tissue et al. (2004) add Twist to this class of E-cadherin repres-
repair in the adult. sors and inducers of EMT. Furthermore, their findings
EMT was recognized as a feature of embryogenesis implicate Twist in tumor cell intravasation, or entry into
in the early 1980s (reviewed in Thiery [2002]). Before the circulation to seed metastases.
the decade was over, EMT had been proposed to be Metastasis is thought to be a multistep process requir-
relevant in cancer as well. This idea was initially met ing the concerted actions of multiple genes. Specific
with skepticism. Pathologists could not say conclusively genes allow tumor cells to overcome barriers to local
that EMT was apparent in human tumor samples. Today, invasion, intravasation, survival in circulation, arrest in
however, a growing body of evidence strongly suggests capillaries, extravasation, and finally outgrowth to pro-
duce macrometastases at distant organs (Chambers et
al., 2002; Fidler, 2003). Mouse models coupled with tran-*Correspondence: j-massague@ski.mskcc.org
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Figure 1. Drivers and Mediators of EMT
Early stage tumor cells (green) maintain epi-
thelial properties similar to the neighboring
normal epithelium (brown). The accidental
overexpression of master regulators of EMT,
such as Twist, Snail, and SIP1, in cancer cells
(shown with purple nuclei) leads to dramatic
changes in gene expression profile and cellu-
lar behavior. Twist, Snail, and SIP1 repress
the expression of E-cadherin via E boxes in its
promoter and trigger expression of an entire
EMT transcriptional program through as yet
unknown mechanisms. Several pathways are
known to regulate Twist, Snail, and SIP1 ex-
pression in tumor cells while others (shown
in parentheses) do so at least in develop-
mental contexts.
scriptomic profiling technology are proving instrumental organisms ranging from Drosophila to vertebrates, Twist
acts as a basic helix-loop-helix transcription factor in ain identifying metastasis genes for each of these steps.
Using mice as a “cell sorter” to select for cells with high signaling cascade that initiates mesoderm development
during gastrulation (Castanon and Baylies, 2002). Through-metastatic ability, it has been possible to identify genes
that enhance lung metastasis by mouse melanoma cells out this process, the invaginating precursors of the
mesoderm lose their epithelial characteristics and gain(Clark et al., 2000) and a set of genes that mediate
metastasis to the bone by human breast cancer (Kang mesenchymal properties, dispersing and spreading out
along the ectoderm to form the mesoderm layer. Thiset al., 2003). These studies were designed to screen for
genes that facilitate the formation of metastases to these epithelial to mesenchymal switch has the features of
classic EMT. Indeed, Yang et al. demonstrated that ec-organs by tumor cells inoculated directly into the circula-
tion, not genes that would facilitate the entrance of tu- topic expression of Twist potently induces EMT in dog
kidney epithelial cells and immortalized human mam-mor cells into the circulation in the first place.
Yang et al. (2004) sought to identify genes in the latter mary epithelial cells in culture. The morphological transi-
tion of these cells from an epithelial to a fibroblasticclass by profiling gene expression in a series of isogenic
tumor cell lines previously derived from a spontaneous appearance was accompanied by scattering and direc-
tional migration toward serum factors, a gain of mesen-mouse breast tumor. These cell lines, when implanted
orthotopically in the mammary fat pads of syngeneic chymal cell markers (fibronectin, vimentin, smooth mus-
cle actin, and N-cadherin), and a loss of epithelialmice, had different abilities to generate lung metastases.
Among the genes overexpressed in the metastatic tu- markers (E-cadherin, and - and -catenin) (Yang et al.,
2004) (Figure 1). Twist represses transcription from themors, transcriptional factor Twist was chosen for de-
tailed study. Through a series of in vivo and in vitro E-cadherin promoter via the E boxes that are also tar-
geted by Snail and SIP1 (Comijn et al., 2001; Nieto, 2002).experiments, Twist was shown to specifically enhance
the intravasation step of metastasis, while having no Twist does not induce Snail expression (Yang et al.,
2004), but it remains to be determined if the interaction ofsignificant effect on the survival, extravasation, or
growth rate of the tumor cells. Elimination of Twist ex- Twist with these E boxes is direct or through a mediator.
Downregulation of E-cadherin alone is not sufficientpression by RNAi in highly metastatic cells dramatically
decreased the efficiency of lung metastasis from the for EMT, as ectopic expression of E-cadherin could not
restore the epithelial phenotype in cells overexpressingmammary gland and specifically decreased the number
of tumor cells that could be recovered from the circula- Twist (Thiery, 2002; Yang et al., 2004). Indeed, loss of
E-cadherin expression and E-cadherin-mediated celltion. No decrease was observed in the ability of Twist-
depleted cells to grow in suspension, arguing that Twist adhesion alone do not constitute EMT. The EMT pro-
gram also includes the acquisition of mesenchymalconfers intravasation capacity rather than resistance to
cell death by suspension. functions. It will be important to identify in the future
the other key downstream targets of Twist that are es-Clues about the mechanism mediating these effects of
Twist came from its role in development. In multicellular sential for initiating EMT and keeping cells in that state
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afterwards. Identification of these genes could lead to large-scale trancriptomic profiling of human tumor sam-
development of new tumor markers as well as new mo- ples have not yielded genes known to be involved in
lecular targets for anticancer drug development. EMT (Ramaswamy et al., 2003; van’t Veer et al., 2002).
During embryonic development, Twist and other mas- A possible explanation for this is that EMT may be a
ter regulators of EMT are expressed under strict spatial- transient process that affects only a small fraction of
temporal control (Castanon and Baylies, 2002). How the tumor cell population at any given time. Therefore,
Twist is activated during tumorgenesis in mouse tumors the transcriptomic contribution of such a population
and human cancers remains unknown. The identification would be diluted by the whole. Carcinoma metastases
of upstream activators of Twist could provide valuable often present an epithelioid phenotype, raising the pos-
information about additional factors that may be impor- sibility that metastatic tumors regain this phenotype
tant in tumor progression. HGF/SF (hepatocyte growth after they reach a target organ. Furthermore, carcinoma
factor/scatter factor), FGF (fibroblast growth factor), and cells that have undergone EMT may be misidentified
EGF (epithelial growth factor), acting through RAS and as stromal components and excluded from analyses
the mitogen-activated protein kinase (MAPK) pathway (Petersen et al., 2003). Further studies including immu-
or phosphoinositide 3-kinase (PI3K) pathway, can po- nohistochemical detection of EMT master regulators like
tently induce EMT in certain epithelial cells in culture Twist in the invasive front of human tumor samples may
(Grunert et al., 2003; Thiery, 2002) (Figure 1). The TGF help establish the true magnitude of the EMT problem
(transforming growth factor )-SMAD pathway syner- in cancer.
gizes with RAS to induce EMT in culture and metastasis
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